Full name
4 PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
78.10.Z - Employment placement and recruitment services
78.30.Z - Employment activities
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | -0,3 | -1,5 | -415,2 |
EBITDA | -0,1 | -0,3 | -1,4 | -449,5 |
Short time liabilities | 1,3 | 1,7 | 2,5 | 47,8 |
Equity capital | 1,3 | 1,1 | -0,4 | -138,4 |
Operating profit (EBIT) | -0,2 | -0,3 | -1,5 | -384,5 |
Assets | 3 | 3,4 | 3 | -11,1 |
Net profit (loss) | -0,2 | -0,2 | -1,5 | -559,2 |
Cash | 0,1 | 0,1 | 0,1 | -24,1 |
Net income from sale | 9,5 | 11,2 | 11,6 | 3,8 |
Liabilities and provisions for liabilities | 1,7 | 2,3 | 3,4 | 47,8 |
Working assets | 2,7 | 3 | 2,8 | -6,7 |
Depreciation | 0 | 0 | 0,1 | 15 |
% | % | % | p.p. | |
Profitability of capital | -12,6 | -21 | 360,1 | 381,1 |
Equity capital to total assets | 43,9 | 31,6 | -13,7 | -45,3 |
Gross profit margin | -1,8 | -2,5 | -12,5 | -10 |
EBITDA Margin | -1,3 | -2,3 | -12,3 | -10 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 49 | 55 | 78 | 23 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane